Cargando…
A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response
Treatment of triple-negative breast cancer (TNBC) is challenging because of its “COLD” tumor immunosuppressive microenvironment (TIME). Here, we present a hydrogel-mediated localized delivery of a combination of docetaxel (DTX) and carboplatin (CPT) (called DTX-CPT-Gel therapy) that ensured enhanced...
Autores principales: | Kar, Animesh, Jain, Dolly, Kumar, Sandeep, Rajput, Kajal, Pal, Sanjay, Rana, Kajal, Kar, Raunak, Jha, Somesh K., Medatwal, Nihal, Yavvari, Prabhu Srinivas, Pandey, Nishant, Mehta, Devashish, Sharma, Harsh, Bhattacharya, Debanjan, Pradhan, Manas K., Sharma, Ravi Datta, Srivastava, Aasheesh, Agrawal, Usha, Mukhopadhyay, Arnab, Sengupta, Sagar, Patil, Veena S., Bajaj, Avinash, Dasgupta, Ujjaini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313169/ https://www.ncbi.nlm.nih.gov/pubmed/37390205 http://dx.doi.org/10.1126/sciadv.adf2746 |
Ejemplares similares
-
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
por: Rajput, Kajal, et al.
Publicado: (2022) -
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
por: Pani, Trishna, et al.
Publicado: (2021) -
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells
por: Pani, Trishna, et al.
Publicado: (2021) -
A Localized Chimeric Hydrogel Therapy Combats Tumor
Progression through Alteration of Sphingolipid Metabolism
por: Pal, Sanjay, et al.
Publicado: (2019) -
A CRACker of an adaptor connects dynein-mediated transport to calcium signaling
por: Sharma, Mahak, et al.
Publicado: (2019)